Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

Egypt · Delayed Price · Currency is EGP

1.350

-0.020 (-1.46%)

At close: Mar 15, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Manufacture and Sale of Cosmetics	894.54M	519.97M	526.01M	729.61M	594.26M
Manufacture and Sale of Cosmetics Growth	72.04%	-1.15%	-27.91%	22.78%	38.04%
Total	894.54M	519.97M	526.01M	729.61M	594.26M
Total Growth	72.04%	-1.15%	-27.91%	22.78%	38.04%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Egypt	863.75M	485.30M	510.98M	699.15M	587.43M
Egypt Growth	77.98%	-5.03%	-26.91%	19.02%	-
Export	30.80M	34.67M	15.02M	30.46M	6.83M
Export Growth	-11.17%	130.77%	-50.68%	345.91%	-
Total	894.54M	519.97M	526.01M	729.61M	594.26M
Total Growth	72.04%	-1.15%	-27.91%	22.78%	-

Source: S&P Global Market Intelligence.